Intellectual Property India Publishes Patent Application for (r) -N-Ethyl-5-Fluoro-N-Isopropyl-2- ( (5- (2- (6- ( (2-Methoxyethyl) (methyl) Amino) -2-Methylhexan-3-Yl) -2, 6-Diazaspiro [3.4] Octan-6-Yl) -1, 2, 4-Triazin-6-Yl) Oxy) Benzamide, Formulations And Dosage Regimens Thereof, For Use In Treating Cancer

MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617059701 A) filed by Janssen Pharmaceutica Nv on May 11, 2026, for (r) -N-Ethyl-5-Fluoro-N-Isopropyl-2- ( (5- (2- (6- ( (2-Methoxyethyl) (methyl) Amino) -2-Methylhexan-3-Yl) -2, 6-Diazaspiro [3.4] Octan-6-Yl) -1, 2, 4-Triazin-6-Yl) Oxy) Benzamide, Formulations And Dosage Regimens Thereof, For Use In Treating Cancer.

Inventors include Ferrante, Lucille Angela; Packman, Kathryn Elizabeth; Cost, Carrye Rudolph; Curtis, Cecil Martin, Jr.; Daskalakis, Nikki; D'Souza, Amber Marie; Guttke, Christina Diane; Jacobs, Frank Bert Raf; Lomas, Oliver Christopher; Miller, Jonathan Jordan; Sanga, Madhu; Tucker, Trevor John; Van Beijsterveldt, Ludovicus Eugenie; Yu, Alex; Ji, Chongmin; Pasha, Mehrdad; Preda, Florentina Maria; Ravelingien, Matthieu Jean M; Sterckx, Hans; Van Rompaey, Elsa; Van Steenwinckel, Marianne Maria G; and Zhu, Donghua.

The application for the patent was published on June 12, 2026, under issue no. 24/2026.

Abstract: The present invention relates to (R) -N-ethyl-5-fluoro-N-isopropyl-2-( (5- (2- (6- ( (2-methoxyethyl) (methyl) amino) -2-methylhexan-3-yl) -2, 6-diazaspiro [3.4] octan- 6-yl) -1,2, 4-triazin-6-yl) oxy) benzamide, and pharmaceutically acceptable salts and solvates thereof, formulations and dosage regimens thereof, for use in treating cancer.

Disclaimer: Curated by HT Syndication.